MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
News

Potential Changes to MS Treatment Access in Australia

MStranslate
July 2, 2026
Treatments
AHSCT in MS

MS Auckland Webinar: AHSCT as a Treatment for MS

MStranslate
June 18, 2026
Research, Stem Cells, Treatments

MS Auckland Webinar: Remyelination Research in MS

MStranslate
April 15, 2026
Cambridge, Remyelination, Research
two doctors, a man and a woman, examine an MRI image of the brain

FDA Decision On Tolebrutinib

MStranslate
January 12, 2026
Clinical Trials
A pair of hands around a crystal ball that has the year 2026 written inside it.

Multiple Sclerosis Research In 2026

MStranslate
January 5, 2026
Progressive MS, Remyelination, Treatments

Announcing Brand New Monday Meet-ups!

MStranslate
June 19, 2015
Events, Google Hangouts
We are pleased to announce that Brett will now be hosting private Google Hangouts every Monday night between 7pm and 8pm. This will be an opportunity to come in and discuss all things related to multiple...
Stem Cell Therapy

Stem Cell Therapy in Multiple Sclerosis

MStranslate
June 18, 2015
Stem Cells, Treatments
A/Prof Helmut Butzkueven from the Melbourne Brain Centre speaks with us to help clear up the confusion surrounding the use of Stem Cell Therapy in multiple sclerosis. He explains how stem cells are currently...

Compound Reduces Neurodegeneration in Mouse Model of MS

MStranslate
June 2, 2015
Research
Researchers from Virginia Commonwealth University and the University of Illinois at Chicago have identified a compound that is able to reduce neurodegeneration in a mouse model of multiple sclerosis. The...

Vitamin D – All About the Timing?

MStranslate
May 19, 2015
Lifestyle, Research, Vitamin D
There has been a long-held belief that low-levels of Vitamin D may increase the risk of developing multiple sclerosis. This has been supported by the worldwide distribution of MS, where lower rates are...

Vitamin B7 – Potential New Therapy for Progressive MS

MStranslate
May 13, 2015
Research, Treatments
Progressive MS is (finally) starting to be a major focus of MS research - both in trying to understand what triggers the shift from the relapsing-remitting form and in the development of effective treatments...

Nanoparticles Used to Deliver Myelin Repair Molecule

MStranslate
May 7, 2015
Research, Treatments
In recent years, a large focus of MS research around the world has been promoting remyelination - that is, the process of repairing damaged nerves. In a recent study published in Biomaterials Science, a team...

PwMS Victoria Annual Conference 2015

MStranslate
May 5, 2015
Conferences, Presentations
A big thank you to the team at People with Multiple Sclerosis - Victoria Incorporated for inviting us to present at their annual conference last Saturday (May 2)!  We could not have asked for a warmer and...

Prolactin: A Novel Therapy for Multiple Sclerosis?

MStranslate
April 23, 2015
Research
By Brett Drummond Prolactin, the hormone responsible for milk production in women, has been previously shown to have the ability to remyelinate damaged nerves.  Therefore, it's potential for use as a...

Psychological Adjustment to Multiple Sclerosis

MStranslate
March 27, 2015
Recruitment, Research
Today, we're featuring a video filmed with clinical psychology student Lis Morley from The University of Melbourne. In it, Lis introduces her research investigating a possible connection between an...

Blood-Brain Barrier Biology – Brian Daniels

MStranslate
March 22, 2015
Research
Could the blood-brain barrier play a role in explaining why more women than men develop multiple sclerosis? While at the recent Keystone Symposia on "Neuroinflammation in Diseases of the Central Nervous...
  1. 25
  2. 26
  3. 27
  4. 28
  5. 29
  6. 30
  7. 31

Recent Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    

Archives

Categories

Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.